National Biomedical Research Act

The National Biomedical Research Act would establish a dedicated "Biomedical Innovation Fund" to provide consistent, long-term funding for the National Institutes of Health (NIH) and the Food and Drug Administration (FDA) through 2030. This legislation aims to accelerate the development of new treatments and diagnostic tools for chronic diseases, particularly those that account for a high percentage of federal healthcare spending. For citizens, the bill is designed to speed up the discovery of cures, improve the safety monitoring of medical products already on the market, and support innovative research into disease prevention.